Management of Post-Thrombolysis Hemorrhagic Conversion in Stroke
If hemorrhagic conversion is suspected after thrombolysis (indicated by declining level of consciousness, blood pressure elevation, motor deterioration, new headache, or nausea/vomiting), immediately stop the rtPA infusion, obtain emergent CT imaging, and administer 6-8 units of cryoprecipitate plus 6-8 units of platelets to reverse the fibrinolytic state 1, 2, 1.
Immediate Recognition and Response
Hemorrhagic transformation occurs in approximately 6.4% of patients treated with IV alteplase 1. You must maintain high vigilance during the critical first 24-36 hours post-thrombolysis. The risk is substantially higher in patients with NIHSS >20 (17% risk) compared to NIHSS <10 (3% risk) 1.
Clinical Signs Requiring Immediate Action:
- Change in level of consciousness
- Blood pressure elevation
- Deterioration in motor examination
- New onset headache
- Nausea and vomiting
When any of these occur: stop rtPA immediately 1.
Algorithmic Management Protocol
Step 1: Immediate Actions (Within Minutes)
- Discontinue rtPA infusion immediately 1
- Notify physician urgently 1
- Obtain emergent CT brain imaging 1
Step 2: Laboratory Assessment (Stat)
Order the following immediately:
- PT/INR
- aPTT
- Fibrinogen level
- Complete blood count with platelets
- Type and cross-match (if not already done) 1
Step 3: Reversal Therapy
Administer empirically while awaiting imaging confirmation:
- Cryoprecipitate: 6-8 units IV (contains factor VIII to reverse fibrinolytic state)
- Platelets: 6-8 units IV 1, 2, 1
This reversal strategy is based on the need to rapidly correct the systemic fibrinolytic state created by tPA, though evidence is limited to expert consensus 2.
Blood Pressure Management
Maintain strict blood pressure control <180/105 mmHg for 24 hours post-thrombolysis 3, 4, 5. After hemorrhagic conversion is confirmed:
- Avoid excessive BP lowering as this may worsen cerebral perfusion in the setting of elevated intracranial pressure 6
- Target BP should balance preventing hematoma expansion while maintaining cerebral perfusion pressure
- Avoid antihypertensive agents that cause cerebral vasodilation 6
Monitoring Protocol
First 24 Hours Post-Thrombolysis:
- Blood pressure: Every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly until 24 hours 1, 5
- Neurological assessment: Complete NIHSS on admission to ICU, then abbreviated assessments more frequently; full NIHSS with any decline 1
- Nurse-to-patient ratio: 1:2 for first 24 hours 1
Neurosurgical Consultation
Obtain immediate neurosurgical consultation after confirming hemorrhagic conversion on imaging 1. Surgical intervention decisions depend on:
- Location and volume of hemorrhage
- Degree of mass effect
- Patient's overall neurological status
- Timing and extent of reversal therapy 2
Critical Pitfalls to Avoid
Do not delay reversal therapy waiting for imaging confirmation - administer cryoprecipitate and platelets empirically when hemorrhagic conversion is clinically suspected 1
Do not use automatic blood pressure cuffs if petechiae develop - this indicates bleeding tendency and cuff trauma can worsen it 1
Avoid invasive procedures for 24 hours post-thrombolysis - no arterial punctures, catheter insertions, or nasogastric tubes unless absolutely necessary 1
Do not aggressively lower blood pressure - excessive drops can worsen cerebral ischemia, particularly with elevated intracranial pressure 6
Additional Supportive Measures
- Use soft sponges instead of toothbrushes for oral care in first 24 hours 1
- Avoid indwelling urinary catheters due to bleeding risk 3
- Monitor for other bleeding sites: retroperitoneal, genitourinary, gastrointestinal 1
- Assess skin for hematomas, ecchymosis, or purpura 1
Prognosis
Hemorrhagic conversion after thrombolysis carries a 30-day mortality rate exceeding 60%, with hemorrhages typically being massive and potentially multifocal 2. However, rapid recognition and aggressive reversal therapy remain the standard of care despite limited definitive evidence for effectiveness 2.